<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02092012</url>
  </required_header>
  <id_info>
    <org_study_id>2013/489</org_study_id>
    <nct_id>NCT02092012</nct_id>
  </id_info>
  <brief_title>Comparison of Preemptive Analgesic Effects of Dexketoprofen Versus Dexmedetomidine on Abdominal Hysterectomy Patients</brief_title>
  <official_title>Comparison of Preemptive Analgesic Effects of Dexketoprofen Versus Dexmedetomidine on the Patients That is Undergoing Abdominal Hysterectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TC Erciyes University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TC Erciyes University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate comparison of preemptive analgesic effects of
      dexketoprofen versus dexmedetomidine on the patients that is undergoing abdominal
      hysterectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Abdominal hysterectomy is associated with moderate to severe postoperative pain which has
      unfavorable effects on patient's recovery and procedure's outcome. Administration of opioid
      analgesics is routinely practiced but is limited with dose-related adverse effects.[1] Within
      this concept, combining an opioid with different analgesics acting by different mechanisms as
      multimodal analgesia is recommended for effective post-operative pain control Dexketoprofen
      trometamol is a newly developed, centrally acting NSAID with potency similar to that of
      μ-opioid agonists.[4] In a number of studies in different pain models, it has been proven to
      have a good analgesic efficacy and tolerability.

      Dexmedetomidine is a highly selective α2 adrenoceptor agonist that provides sedation,
      analgesia, and sympatholysis. These characteristics make dexmedetomidine useful anesthetic
      adjunct during operation. Previous studies report that intravenous has a definitive role in
      postoperative analgesia through the reduction of opioid consumption The aim of this
      prospective randomized, double-blind study is to evaluate the analgesic efficacy and opioid
      sparing effects of preemptive single dose of dexketoprofen trometamol in comparison with
      dexmedetomidine in the patients abdominal hysterectomy , over a 24-hour (h) investigation
      period.

      After institutional approval and informed consent had been obtained, 60 patients scheduled
      for abdominal hysterectomy randomly allocated into two equal groups. Patients received ıv
      dexketoprofen 50 mg (Group I), ıv dexmedetomidine 1mcg/kg (Group II) after anesthesia
      induction and 10 minutes (min) before surgical incision. Patient controlled analgesia was
      supplied postoperatively using morphine. Hemodynamics, visual analogue scale (VAS), sedation
      score, morphine consumption, and side effects were recorded every and at 2, 6, 12 and 24 h
      after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analog Scale</measure>
    <time_frame>postoperative 1 day</time_frame>
    <description>Visual Analog Scale on rest and movement record</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>analgesic consumption</measure>
    <time_frame>postoperative 1 day</time_frame>
    <description>morphine consumption with patient controlled analgesia record</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>dexketoprofen trometamol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ıv 50 mg dexketoprofen trometamol after anesthesia induction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>dexmedetomidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ıv 1 mcg/kg dexmedetomidine after anaesthesia induction</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexketoprofen trometamol</intervention_name>
    <description>ıv 50 mg dexketoprofen trometamol after anaesthesia induction</description>
    <arm_group_label>dexketoprofen trometamol</arm_group_label>
    <other_name>arveles</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>ıv 1 mcg/kg dexmedetomidine after anaesthesia induction</description>
    <arm_group_label>dexmedetomidine</arm_group_label>
    <other_name>precedex</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18- 65 year female

          -  Scheduled for elective abdominal hysterectomy

          -  No known allergies to drugs

          -  ASA I-II patients

        Exclusion Criteria:

          -  Pregnancy

          -  Drug or alcohol abuse

          -  History of allergic reaction to any of the study drugs

          -  Ongoing opioid, and non-steroidal anti-inflammatory

          -  Analgesic therapy

          -  Cardiac, respiratory, hepatic and/or renal failure

          -  History of peptic ulcer disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>selda kayaaltı, resident</last_name>
    <role>Principal Investigator</role>
    <affiliation>erciyes univercity medicine faculty</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>selda kayaaltı, resident</last_name>
    <phone>+905558168918</phone>
    <email>drselda@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>fatih ugur, assoc</last_name>
    <phone>+905359730073</phone>
    <email>ugurf@erciyes.edu.tr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Erciyes Univercity Medicine Faculty</name>
      <address>
        <city>Kayseri</city>
        <zip>38039</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>selda kayaaltı, resident</last_name>
      <phone>+905558168918</phone>
      <email>drselda@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>fatih ugur, assoc</last_name>
      <phone>+905359730073</phone>
      <email>ugurf@erciyes.edu.tr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2014</study_first_submitted>
  <study_first_submitted_qc>March 18, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2014</study_first_posted>
  <last_update_submitted>March 20, 2014</last_update_submitted>
  <last_update_submitted_qc>March 20, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 21, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>TC Erciyes University</investigator_affiliation>
    <investigator_full_name>SELDA KAYAALTI, MD</investigator_full_name>
    <investigator_title>resident</investigator_title>
  </responsible_party>
  <keyword>postoperative pain</keyword>
  <keyword>dexketoprofen trometamol</keyword>
  <keyword>dexmedetomidine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Dexketoprofen trometamol</mesh_term>
    <mesh_term>Ketoprofen</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

